Sign in
CompletedNo phase

Pleth Variability Index in Pulmonary Embolism

Key facts

Who runs it
Suleyman Demirel University
Where
Türkiye1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
1 person enrolled
Started
1 Apr 2023
Ended
1 Jun 2024
Type of study
Observational
Treatments tested
  • Masimo Radical-7® Pulse CO-Oximeter
Record updated
18 July 2024

Who can take part

Age
18 years to 93 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • To be over 18 years old
  • Diagnosis of pulmonary embolism

Who cannot take part

  • patients had asthma and chronic obstructive pulmonary disease exacerbation
  • patients had acute decompensated heart failure
  • patient was under 18 years old
  • patients were pregnant

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Pulmonary embolism(PE) is a ventilation/perfusion disorder caused by obstruction of the pulmonary artery, usually by a thrombus. The Pleth Variability Index(PVI) is a continuous, noninvasive indicator of dynamic perfusion index changes in photoplethysmography that occur in at least one respiratory cycle. The aim of this study is to evaluate the prognostic and mortality indicator role of PVI in patients with PE, hypothesizing that PVI could serve as a valuable guide in this disease where perfusion impairment is fundamental.

Read full original descriptionShow less

Based on our study, we determined that PVI could be a non-invasive, rapid, and objective tool for predicting disease progression and mortality in PE patients in the emergency department. Our study is the first to evaluate the PVI in PE.

The group in the trial

  • patients diagnosed pulmonary embolism

    Patients over the age of 18 who presented to the emergency department of a tertiary care hospital with complaints of cough, dyspnea, chest pain, tachycardia, hemoptysis, and syncope, and were diagnosed with pulmonary embolism (PE) confirmed by pulmonary computed tomographic angiography (CTPA), were included in our study. Informed consent was obtained from the patients who were stable and from the relatives of the patients who were unstable. Plethysmographic variability index (PVI) and Perfusion index (PI) levels were automatically obtained 2 minutes after the device was attached, using a probe placed on the index finger of the hand while the patient was lying supine. PI and PVI measurements and data were collected consecutively by the same individual. The measurements were taken using the Masimo Radical-7® Pulse CO-Oximeter, which is approved by the U.S. Food and Drug Administration.

    Treatment: Masimo Radical-7® Pulse CO-Oximeter

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Pleth Variability Index: A Potential New Marker for Predicting the Mortality of Pulmonary Embolism?
Publications
Record updated
18 July 2024